AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Stem cell researcher reports year-end 2002 net loss at $0.19.

Vaccine Weekly

| October 16, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 OCT 16 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced financial results for its fourth quarter and fiscal year ended June 30, 2002.

The company reported that it completed the year with sufficient cash to fund operations for the coming fiscal year. In addition to the year-end cash assets, Aastrom intends to seek financing to fund future operations.

For the quarter ended June 30, 2002, Aastrom reported a net loss of $2.0 million, compared with a net loss of $1.9 million for the same period last year. For fiscal year 2002, the company reported a net loss of $7.9 million, compared with a net loss of $5.9 million in 2001. ...

Related articles from newspapers, magazines, journals, and more
AUSTRALIA'S BRESAGEN POSTS H1 NET LOSS OF US$3.6 MLN.
News wire article from: AsiaPulse News March 14, 2003 700+ words
...booked a higher interim net loss of $A6.1 million...million) today. The stem cell researcher is looking...BresaGen today booked a net loss for the six months to...million), compared to a net loss of $A3.9 million...
Stem cell company announces third quarter 2002 financial results.(StemCells...
Magazine article from: Stem Cell Week December 16, 2002 700+ words
...2002. StemCells' net loss was $2.7 million before...2002, compared with a net loss of $1.8 million...strategic assets in the stem cell field," commented Martin...recognize the value of our stem cell technology. While there...
Cell Robotics' Reports Second Quarter Results Workstation Sales Growth Related...
Press release article from: PR Newswire August 14, 2001 700+ words
...period in 2000. The Company incurred a net loss of $684,033 or $(0.07) per diluted...the 2nd quarter of 2001 compared to a net loss of $812,403 or $(0.09) per diluted...improvement over the same period in 2000. The net loss for the six-months ended June 30, 2001...
Stem cell company announces third quarter 2002 financial results.
Newspaper article from: Biotech Week December 18, 2002 700+ words
...2002. StemCells' net loss was $2.7 million before...2002, compared with a net loss of $1.8 million...strategic assets in the stem cell field," commented Martin...recognize the value of our stem cell technology. While there...
Stem cell banking firm reports 80% increase in revenues.
Newspaper article from: Drug Week May 14, 2004 700+ words
...000, compared to a net loss of approximately...decision to close Stem Cell Preservation Technologies...operations resulting in a net loss from discontinued...000, compared to a net loss from continuing operations...and expansion of stem cell preservation ...
Basking in glow of stem-cell discovery: BUT POLITICAL, ECONOMIC ISSUES COULD...
Newspaper article from: San Jose Mercury News (San Jose, CA) August 26, 2006 700+ words
...attracted some leading stem-cell experts. Its chairman...Geron, a Menlo Park stem-cell firm. Initially, Advanced...for its human embryonic stem-cell research, which it concluded...last year reported a net loss of $9.4 million...
Stem Cell Therapeutics Corp. Reports First Quarter 2005 Results.
Press release article from: PR Newswire May 11, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp...Company's subsidiary, Stem Cell Therapeutics Inc on January...Review SCT recorded a net loss for the three month period...development plan. About Stem Cell Therapeutics Corp...
Stem Cell Therapeutics Corp. Reports Second Quarter 2005 Results.
Press release article from: PR Newswire August 23, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp. ("SCT...Financial Review SCT recorded a net loss for the six month period ended...our development plan. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA